Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Hunter Immunology‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
David Radford | Chief Executive Officer |